{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T10:22:59Z","timestamp":1793701379365,"version":"4.5.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["journal-of-hepatology.eu","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.jhep.2015.04.025","type":"journal-article","created":{"date-parts":[[2015,5,8]],"date-time":"2015-05-08T12:07:46Z","timestamp":1431086866000},"page":"586-592","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":158,"title":["Delta hepatitis within the Veterans Affairs medical system in the United States: Prevalence, risk factors, and outcomes"],"prefix":"10.1016","volume":"63","author":[{"given":"Tatyana","family":"Kushner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Serper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2015.04.025_b0005","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s11894-013-0365-x","article-title":"Hepatitis delta: epidemiology, diagnosis and management 36 years after discovery","volume":"16","author":"Noureddin","year":"2014","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.jhep.2015.04.025_b0010","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1111\/jgh.12217","article-title":"Coinfection with hepatitis B and D: epidemiology, prevalence and disease in patients in Northern California","volume":"28","author":"Gish","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2015.04.025_b0015","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1093\/infdis\/155.5.931","article-title":"Influence of hepatitis delta virus infection on progression to cirrhosis in chronic hepatitis type B","volume":"155","author":"Fattovich","year":"1987","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jhep.2015.04.025_b0020","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1136\/gut.46.3.420","article-title":"Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B. The European Concerted Action on Viral Hepatitis (Eurohep)","volume":"46","author":"Fattovich","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2015.04.025_b0025","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1086\/655808","article-title":"Prevalence, correlates, and viral dynamics of hepatitis delta among injection drug users","volume":"202","author":"Kucirka","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jhep.2015.04.025_b0030","doi-asserted-by":"crossref","first-page":"S555","DOI":"10.2105\/AJPH.2014.302090","article-title":"Impact of race\/ethnicity and gender on HCV screening and prevalence among U.S. veterans in Department of Veterans Affairs Care","volume":"104","author":"Backus","year":"2014","journal-title":"Am J Public Health"},{"key":"10.1016\/j.jhep.2015.04.025_b0035","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/hep.20289","article-title":"Risk of diabetes in HIV infected veterans pre- and post-HAART and the role of HCV coinfection","volume":"40","author":"Butt","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.04.025_b0040","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1111\/apt.12923","article-title":"Nonalcoholic fatty liver disease (NAFLD) in the Veterans Administration population: development and validation of an algorithm for NAFLD using automated data","volume":"40","author":"Husain","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2015.04.025_b0045","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/pds.2148","article-title":"Validity of diagnostic codes and liver-related laboratory abnormalities to identify hepatic decompensation events in the Veterans Aging Cohort Study","volume":"20","author":"Lo Re","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jhep.2015.04.025_b0050","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/pds.3290","article-title":"Validation of three coding algorithms to identify patients with end-stage liver disease in an administrative database","volume":"21","author":"Goldberg","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jhep.2015.04.025_b0055","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1001\/archinte.158.16.1789","article-title":"The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test","volume":"158","author":"Bush","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jhep.2015.04.025_b0060","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1478-7954-4-2","article-title":"Accuracy and completeness of mortality data in the Department of Veterans Affairs","volume":"4","author":"Sohn","year":"2006","journal-title":"Popul Health Metr"},{"key":"10.1016\/j.jhep.2015.04.025_b0065","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.jhep.2013.07.005","article-title":"Prevalence and clinical course of hepatitis delta infection in Greece: a 13-year prospective study","volume":"59","author":"Manesis","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.04.025_b0070","doi-asserted-by":"crossref","first-page":"e8210","DOI":"10.5812\/hepatmon.8210","article-title":"Prevalence of hepatitis d in the eastern mediterranean region: systematic review and meta analysis","volume":"13","author":"Amini","year":"2013","journal-title":"Hepat Mon"},{"key":"10.1016\/j.jhep.2015.04.025_b0075","first-page":"95","article-title":"Seroprevalence of serum HBsAg positivity and hepatitis delta virus infection among blood donors in Southeastern Turkey","volume":"165","author":"Mese","year":"2014","journal-title":"Clin Ter"},{"key":"10.1016\/j.jhep.2015.04.025_b0080","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1365-2893.2010.01329.x","article-title":"Prevalence of hepatitis delta virus (HDV) infection in chronic hepatitis B patients in eastern Turkey: still a serious problem to consider","volume":"18","author":"Bahcecioglu","year":"2011","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhep.2015.04.025_b0085","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0035-9203(97)90374-6","article-title":"Seroepidemiology of hepatitis B, C and delta viruses in Tunisia","volume":"91","author":"Triki","year":"1997","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.jhep.2015.04.025_b0090","first-page":"260","article-title":"Seroprevalence and risk factors of hepatitis delta virus in chronic hepatitis B virus infection in Zahedan","volume":"51","author":"Bakhshipour","year":"2013","journal-title":"Acta Med Iran"},{"key":"10.1016\/j.jhep.2015.04.025_b0095","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1111\/j.1440-1746.2005.03857.x","article-title":"Epidemiology and clinical pattern of hepatitis delta virus infection in Pakistan","volume":"20","author":"Mumtaz","year":"2005","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2015.04.025_b0100","doi-asserted-by":"crossref","first-page":"343","DOI":"10.5144\/0256-4947.2004.343","article-title":"Prevalence of hepatitis delta antibody among HBsAG carriers in Saudi Arabia","volume":"24","author":"Al-Traif","year":"2004","journal-title":"Ann Saudi Med"},{"key":"10.1016\/j.jhep.2015.04.025_b0105","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1590\/S0037-86822012000600007","article-title":"Hepatitis D virus infection in the Western Brazilian Amazon \u2013 Far from a vanishing disease","volume":"45","author":"Braga","year":"2012","journal-title":"Rev Soc Bras Med Trop"},{"key":"10.1016\/j.jhep.2015.04.025_b0110","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/jmv.20482","article-title":"High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia","volume":"77","author":"Tsatsralt-Od","year":"2005","journal-title":"J Med Virol"},{"key":"10.1016\/j.jhep.2015.04.025_b0115","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/jmv.23653","article-title":"Coinfection of hepatitis B and hepatitis delta virus in Belgium: a multicenter BASL study. Prospective epidemiology and comparison with HBV mono-infection","volume":"85","author":"Ho","year":"2013","journal-title":"J Med Virol"},{"key":"10.1016\/j.jhep.2015.04.025_b0120","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jinf.2013.02.006","article-title":"A re-assessment of the epidemiology and patient characteristics of hepatitis D virus infection in inner city London","volume":"66","author":"William Tong","year":"2013","journal-title":"J Infect"},{"key":"10.1016\/j.jhep.2015.04.025_b0125","doi-asserted-by":"crossref","first-page":"7635","DOI":"10.3748\/wjg.v20.i24.7635","article-title":"Epidemiology of acute and chronic hepatitis B and delta over the last 5 decades in Italy","volume":"20","author":"Sagnelli","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2015.04.025_b0130","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.23190","article-title":"Chronic hepatitis B: update 2009","volume":"50","author":"Lok","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.04.025_b0135","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.3109\/10826089609063969","article-title":"Validity of self-reported drug use in high risk populations: a meta-analytical review","volume":"31","author":"Magura","year":"1996","journal-title":"Subst Use Misuse"},{"key":"10.1016\/j.jhep.2015.04.025_b0140","unstructured":"Serper M CG, Forde KA, Kaplan DE. Care Quality and Outcomes among U.S. Veterans with Hepatitis B: A National Cohort Study. Under Review. 2014."},{"key":"10.1016\/j.jhep.2015.04.025_b0145","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/ajg.2014.72","article-title":"Poor adherence to AASLD guidelines for chronic hepatitis B Management and treatment in a large academic medical center","volume":"109","author":"Wu","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2015.04.025_b0150","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1186\/1743-422X-7-283","article-title":"Prevalence of hepatitis delta virus infection among hepatitis B virus surface antigen positive patients circulating in the largest province of Pakistan","volume":"7","author":"Zaidi","year":"2010","journal-title":"Virol J"},{"key":"10.1016\/j.jhep.2015.04.025_b0155","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1017\/S0950268806007643","article-title":"Current prevalence of hepatitis delta virus (HDV) infection and the range of HDV genotypes in Lebanon","volume":"135","author":"Ramia","year":"2007","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.jhep.2015.04.025_b0160","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ijid.2005.10.012","article-title":"Hepatitis delta virus (HDV) genotypes in patients with chronic hepatitis: molecular epidemiology of HDV in Turkey","volume":"11","author":"Altuglu","year":"2007","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jhep.2015.04.025_b0165","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1056\/NEJM199401133300202","article-title":"Treatment of chronic hepatitis D with interferon alfa-2a","volume":"330","author":"Farci","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2015.04.025_b0170","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/hep.21296","article-title":"Pegylated interferon alpha-2b as monotherapy or in combination with ribavirin in chronic hepatitis delta","volume":"44","author":"Niro","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.04.025_b0175","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/hep.21325","article-title":"Efficacy of peginterferon alpha-2b in chronic hepatitis delta: relevance of quantitative RT-PCR for follow-up","volume":"44","author":"Castelnau","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.04.025_b0180","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/hep.27102","article-title":"Late HDV RNA relapse after peginterferon alpha-based therapy of chronic hepatitis delta","volume":"60","author":"Heidrich","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.04.025_b0185","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa0912696","article-title":"Peginterferon plus adefovir versus either drug alone for hepatitis delta","volume":"364","author":"Wedemeyer","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2015.04.025_b0190","unstructured":"Koh C, Haynes-Williams V, Hoofnagle JH, et al. Prenylation inhibition with lonafarnib decreases hepatitis D levels in humans. The Liver Meeting 2014: Annual Meeting of the American Association for the Study of Liver Diseases, 2014: Abstract 1860."},{"key":"10.1016\/j.jhep.2015.04.025_b0195","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.jhep.2012.12.008","article-title":"The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus","volume":"58","author":"Volz","year":"2013","journal-title":"J Hepatol"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827815003190?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827815003190?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,22]],"date-time":"2018-09-22T15:27:53Z","timestamp":1537630073000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827815003190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0168827815003190"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2015.04.025","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Delta hepatitis within the Veterans Affairs medical system in the United States: Prevalence, risk factors, and outcomes","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2015.04.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}